Erlotinib and dehydration Patient Reports February 11, 2012

Erlotinib Side Effects Report #5055970-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on July 07, 2006. Male patient, 48 years of age, was diagnosed with tonsil cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood chloride decreased, blood sodium decreased, candidiasis, decreased appetite, dehydration, dysphagia, malaise, mucosal inflammation. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, CISPLATIN, AUGMENTIN, NYSTATIN, DURAGESIC. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5324241-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 23, 2007. Female patient, 77 years of age, weighting 136.0 lb, was diagnosed with squamous cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atrial fibrillation

, blood creatine phosphokinase abnormal, dehydration, haematocrit decreased, haemoglobin decreased, loss of consciousness, mucosal inflammation, syncope, urinary tract infection

. Erlotinib dosage: unknown. During the same period patient was treated with LORTAB, PRILOSEC, ASPIRIN, PLAVIX, DIFLUXAN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5098898-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 17, 2006. Female patient, 56 years of age, weighting 182.0 lb, was diagnosed with squamous cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anxiety

, dehydration, diarrhoea, dizziness

, dysphagia, epistaxis, hypoaesthesia, hypoglycaemia, mouth haemorrhage. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with ZANTAC, INDERAL LA, GLUCOPHAGE, MIRAPEX, LOPID, GLIPIZIDE, FISH OIL, WELLBUTRIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6090979-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 20, 2009. Male patient, 40 years of age, weighting 127.5 lb, was diagnosed with sinus disorder, squamous cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood chloride decreased, chills, constipation

, dehydration, haematocrit decreased, haemoglobin decreased, hyperhidrosis, hypophagia, nausea

. Erlotinib dosage: 100MG/ORAL/DAILY. During the same period patient was treated with BEVACIZUMAB, ACETAMINOPHEN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6025813-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Dec 17, 2008. Male patient, 57 years of age, weighting 198.2 lb, was diagnosed with renal cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: carbon dioxide decreased, cholangitis, cholecystitis, cholelithiasis, dehydration. Erlotinib dosage: (50 MG,QD),ORAL; (50 MILLICURIES,QD),ORAL. During the same period patient was treated with SUNITINIB MALATE, ACETAMINOPHEN, NEXIUM, AMLODIPINE, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5792705-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on June 10, 2008. Male patient, 69 years of age, weighting 153.0 lb, was diagnosed with renal cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypotension, myocardial infarction. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with RAPAMUNE, BENZACLIN, DICYCLOMINE, LOMOTIL, DOXAZOSIN, FINASTERIDE, FUROSEMIDE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5578434-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 12, 2007. Male patient, 77 years of age, was diagnosed with prostate cancer

and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, hypoxia, pneumocystis jiroveci pneumonia, pulmonary fibrosis

, pyrexia. Erlotinib dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5586222-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Dec 21, 2007. Male patient, 77 years of age, was diagnosed with prostate cancer

and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, pneumocystis jiroveci pneumonia. Erlotinib dosage: 150 MG, QD) ORAL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5143978-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 02, 2006. Male patient, 69 years of age, was diagnosed with prostate cancer

and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, hypotension, tremor. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5186693-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 27, 2006. Male patient, 69 years of age, was diagnosed with prostate cancer

and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abasia, cough, dehydration, delusion, difficult to wean from ventilator, disease progression, dizziness

, dyskinesia, dysstasia. Erlotinib dosage: 150 MG QD, ORAL. Patient was hospitalized. Patient died on 09/23/2006.

Erlotinib Side Effects Report #6125376-9
Erlotinib side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Mar 02, 2009. Male patient, 77 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood calcium decreased, dehydration, hypophagia, hypotension, platelet count decreased. Erlotinib dosage: 100 MG QD, ORAL. Patient recovered.

Erlotinib Side Effects Report #5203396-6
Erlotinib side effect was reported by a Physician from PERU on Dec 21, 2006. Male patient, 74 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, dehydration, diarrhoea, haemoglobin decreased, hypovolaemic shock, malabsorption, no therapeutic response. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE. Patient was hospitalized and became disabled. Patient died.

Erlotinib Side Effects Report #5517710-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 26, 2007. Female patient, 72 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood sodium decreased, dehydration, disease progression, lymphocyte count decreased, thrombocytopenia. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, COLACE, COMPAZINE, DILAUDID, FLUCONAZOLE, GLYBURIDE, MIRALAX. Patient recovered.

Erlotinib Side Effects Report #5286987-6
Erlotinib side effect was reported by a Physician from PERU on Mar 14, 2007. Female patient, 54 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, aspartate aminotransferase increased, blood glucose increased, dehydration, gastrointestinal infection, prothrombin time prolonged. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, GLYBURIDE, METFORMIN, ALPRAZOLAM, ACETAMINOPHEN, OMEPRAZOLE, TRAMADOL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5380022-7
Erlotinib side effect was reported by a Physician from PERU on June 18, 2007. Female patient, 54 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, aspartate aminotransferase increased, blood glucose increased, dehydration, diarrhoea, nausea

, prothrombin time prolonged, pyrexia. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, GLYBURIDE, METFORMIN, ALPRAZOLAM, ACETAMINOPHEN, OMEPRAZOLE, TRAMADOL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5744847-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 02, 2008. Male patient, 75 years of age, weighting 164.9 lb, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arthralgia, blood sodium decreased, candidiasis, confusional state, dehydration, haematocrit decreased, haemoglobin decreased, herpes simplex

. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with EVEROLIMUS, GLIMEPIRIDE, NORVASC, PRILOSEC, SENOKOT, MIRALAX, REGLAN, DOXYCYCLINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5764810-0
Erlotinib side effect was reported by a Physician from UNITED STATES on May 19, 2008. Male patient, 75 years of age, weighting 164.9 lb, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arthralgia, ascites, asthenia, blood albumin decreased, candidiasis, confusional state, dehydration, failure to thrive. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with EVEROLIMUS, GLIMEPIRIDE, NORVASC, PRILOSEC, SENOKOT, MIRALAX, REGLAN, DOXYCYCLINE. Patient was hospitalized. Patient died on 05/17/2008.

Erlotinib Side Effects Report #6132638-8
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 09, 2009. Female patient, 60 years of age, weighting 125.2 lb, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: culture urine positive, dehydration, escherichia infection, mucosal inflammation, platelet count decreased, pneumonia klebsiella, vomiting. Erlotinib dosage: (100 MG,QD),ORAL. During the same period patient was treated with GEMCITABINE, XELODA. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5729791-4
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 18, 2008. Male patient, 53 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, duodenal obstruction, hypotension, renal impairment. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, XELODA, GEMCITABINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5803926-7
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on June 19, 2008. Male patient, 53 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain

, blood creatinine increased, blood urea increased, body temperature increased, dehydration, duodenal obstruction, hypophagia, hypotension, intestinal perforation. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, LANSOPRAZOLE, PANCREATIN TRIPLE STRENGTH CAP. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5818445-1
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on July 02, 2008. Male patient, 53 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain

, blood creatinine increased, blood urea increased, body temperature increased, dehydration, duodenal obstruction, hypophagia, hypotension, lymphocyte count increased. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, CAPECITABINE, GEMCITABINE, LANSOPRAZOLE, PANCREATIN TRIPLE STRENGTH CAP. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5744848-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 02, 2008. Female patient was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypokalaemia, vomiting. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with EVEROLIMUS, AUGMENTIN, CELEXA, CENTRUM, ESTROGEN PATCH, LORTAB, NEXIUM, ZOFRAN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5822141-4
Erlotinib side effect was reported by a Physician from AUSTRIA on July 10, 2008. Female patient, 79 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, catheter site infection, dehydration, dysphagia, nervous system disorder, parkinsonism, performance status decreased, speech disorder, urticaria. Erlotinib dosage: 150 MG (150 MG, QD), ORAL; 150 MG (QD), ORAL. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DIGIMERCK, PANTOPRAZOLE, LASIX, DURAGESIC, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5942619-2
Erlotinib side effect was reported by a Physician from AUSTRIA on Oct 17, 2008. Female patient, 79 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, c-reactive protein increased, central line infection, dehydration, dysphagia, hypoglycaemia, parkinsonism, performance status decreased, progressive supranuclear palsy

. Erlotinib dosage: 150 MG (150 MG,QD), ORAL; 150 MG (QD), ORAL. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DIGIMERCK, PANTOPRAZOLE, LASIX, DURAGESIC, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5300467-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 26, 2007. Female patient, 57 years of age, weighting 160.0 lb, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, hypertension, nausea

. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, ATIVAN, ANZEMET. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4812003-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 27, 2005. Female patient, weighting 158.7 lb, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, coagulopathy, culture urine positive, dehydration, depression

, dizziness

, lactobacillus infection, liver function test abnormal, nausea

. Erlotinib dosage: 150MG/PER DAY BY MOUTH. During the same period patient was treated with BEVACIZUMAB, COUMADIN, PAXIL, DOXYCYCLINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4740923-7
Erlotinib side effect was reported by a Physician from UNITED STATES on July 19, 2005. Female patient, 57 years of age, weighting 179.9 lb, was diagnosed with oligodendroglioma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, myocardial infarction, nausea

. Erlotinib dosage: unknown. During the same period patient was treated with TEMSIROLIMUS. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5877487-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 25, 2008. Male patient, 72 years of age, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anorexia, asthenia, atrial flutter, dehydration, fatigue, haematocrit decreased, haemoglobin decreased, sinus tachycardia. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, BACTRIM, ALBUTEROL, ESOMEPRAZOLE MAGNESIUM. Patient recovered.

Erlotinib Side Effects Report #5779170-9
Erlotinib side effect was reported by a Physician from UNITED STATES on June 02, 2008. Female patient, 67 years of age, weighting 156.5 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal discomfort, aortic stenosis, asthenia, atrial fibrillation

, dehydration, dizziness

, gait disturbance, hiccups, hypotension. Erlotinib dosage: 100 MG, ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, GLIPIZIDE, BENAZEPRIL, PLAVIX, METOPROLOL TARTRATE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5808287-5
Erlotinib side effect was reported by a Physician from UNITED STATES on June 02, 2008. Female patient, 67 years of age, weighting 156.5 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal discomfort, aortic stenosis, asthenia, atrial fibrillation

, dehydration, dizziness

, ejection fraction decreased, gait disturbance, hiccups. Erlotinib dosage: (100 MG), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, GLIPIZIDE, BENAZEPRIL, PLAVIX, METOPROLOL TARTRATE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5908423-6
Erlotinib side effect was reported by a Physician from UNITED STATES on Sept 15, 2008. Male patient, 66 years of age, weighting 186.1 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, dysphagia, leukopenia, lip pain, mucosal inflammation, oesophagitis, oral pain. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL, CARBOPLATIN, PACLITAXEL, OXYCODONE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6140496-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 17, 2009. Female patient, 65 years of age, weighting 138.9 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, dehydration, dysphagia, mucosal inflammation, nausea

, white blood cell count decreased. Erlotinib dosage: (100 MG,QD),ORAL. During the same period patient was treated with BEVACIZUMAB, TAXOL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5775135-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 28, 2008. Male patient, 64 years of age, weighting 138.9 lb, was diagnosed with oesophageal carcinoma, multiple myeloma

and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: choking

, dehydration, diarrhoea, epistaxis, nausea

, oesophagitis, oral pain, weight decreased. Erlotinib dosage: (100 MG,QD) ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5797454-5
Erlotinib side effect was reported by a Physician from UNITED STATES on June 12, 2008. Male patient, 64 years of age, weighting 138.9 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: choking

, dehydration, diarrhoea, epistaxis, nausea

, odynophagia, oesophagitis, oral pain. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5407966-1
Erlotinib side effect was reported by a Physician from UNITED STATES on July 19, 2007. Male patient, 60 years of age, weighting 166.4 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest discomfort, chest pain

, dehydration, diarrhoea, dyspnoea, hyperglycaemia, hyperhidrosis, hyponatraemia, hypotension. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5420941-6
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 03, 2007. Male patient, 60 years of age, weighting 166.4 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, chest pain

, dehydration, diarrhoea, dyspnoea, hyperglycaemia, hyperhidrosis, hyponatraemia, hypotension. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6083750-3
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 03, 2009. Male patient, 58 years of age, weighting 186.1 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, dehydration, diarrhoea, dysphagia, febrile neutropenia, penis disorder

, vomiting, white blood cell count decreased. Erlotinib dosage: 100 MG, DAYS 1-42, ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, ROXICET, DOXYCYCLINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5808286-3
Erlotinib side effect was reported by a Physician from UNITED STATES on June 24, 2008. Female patient, weighting 72.09 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood potassium decreased, dehydration, discomfort, dysphagia, failure to thrive, interstitial lung disease, pain

, pancytopenia. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5819960-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on July 07, 2008. Female patient, weighting 72.09 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain upper, blood calcium decreased, blood potassium decreased, clostridium difficile colitis, dehydration, discomfort, dysphagia, failure to thrive. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5834179-1
Erlotinib side effect was reported by a Physician from UNITED STATES on July 16, 2008. Female patient, weighting 72.09 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood calcium decreased, blood potassium decreased, clostridium difficile colitis, dehydration, discomfort, dysphagia, failure to thrive. Erlotinib dosage: (100 MG,QD) ,ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5808286-3
Erlotinib side effect was reported by a Physician from UNITED STATES on June 24, 2008. Female patient, weighting 72.09 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood potassium decreased, dehydration, discomfort, dysphagia, failure to thrive, interstitial lung disease, pain

, dehydration, haemoglobin decreased, weight decreased. Erlotinib dosage: 125 MG, QD, ORAL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5487272-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Sept 28, 2007. Male patient, 86 years of age, weighting 182.3 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cachexia, dehydration, failure to thrive, hyperglycaemia, unresponsive to stimuli. Erlotinib dosage: 150 MG (150 MG, QD), ORAL. Patient was hospitalized. Patient died on 09/18/2007.

Erlotinib Side Effects Report #5822414-5
Erlotinib side effect was reported by a Physician from AUSTRALIA on July 07, 2008. Male patient, 85 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, dehydration, nausea

, weight decreased. Erlotinib dosage: 100 MG QD ORAL. During the same period patient was treated with GEMCITABINE, ASPIRIN, METOCLOPRAMIDE, LOPERAMIDE, RANITIDINE. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5483736-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 09, 2007. Female patient, 78 years of age, weighting 184.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: decreased appetite, dehydration, malaise, nausea

, pyrexia. Erlotinib dosage: 150 MG DAILY 047. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5638845-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 22, 2008. Female patient, 78 years of age, weighting 184.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, pyrexia. Erlotinib dosage: 150 MG DAILY 047. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6060242-9
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Jan 14, 2009. Male patient, 78 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypotension, lower respiratory tract infection, malignant neoplasm progression, non-small cell lung cancer, pneumonia

. Erlotinib dosage: (150 MG, QD) ,ORAL. Patient was hospitalized. Patient died on 01/01/2009.

Erlotinib Side Effects Report #5748902-8
Erlotinib side effect was reported by a Physician from AUSTRALIA on May 07, 2008. Male patient, 77 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, atrial fibrillation

, blood calcium decreased, blood glucose increased, blood urea increased, dehydration, emphysema, lymphangitis, syncope. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with GEMCITABINE, PREDNISOLONE, DIAMICRON, COTAZYM, LOFENOXAL, CLONAZEPAM, METOCLOPRAMIDE, ASPIRIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5250757-5
Erlotinib side effect was reported by a Physician from GERMANY on Feb 09, 2007. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, chest pain

, constipation

, dehydration, disease progression, fall

, infection

. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with OXYCODONE, MOVICOL, NEXIUM, NOVALGIN, INSULIN, METOCLOPRAMID, SPIRONOLACTONE. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5386371-0
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on June 25, 2007. Female patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, oral intake reduced, rash

. Erlotinib dosage: unknown. Patient died.

Erlotinib Side Effects Report #5634112-1
Erlotinib side effect was reported by a Physician from GERMANY on Feb 14, 2008. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, chest pain

, constipation

, dehydration, disease progression, fall

, infection

, nausea

. Erlotinib dosage: 150 MG (150 MG, QD), ORAL. During the same period patient was treated with OXYCODONE, MOVICOL, NEXIUM, NOVALGIN, INSULIN, METOCLOPRAMID, SPIRONOLACTONE. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5670074-9
Erlotinib side effect was reported by a Physician from GERMANY on Feb 26, 2008. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: constipation

, dehydration, fall

, infection

, malignant neoplasm progression, nausea

. Erlotinib dosage: 150 MG (150 MG, QD), ORAL. During the same period patient was treated with OXYCODONE, MOVICOL, NEXIUM, NOVALGIN, INSULIN, METOCLOPRAMID, SPIRONOLACTONE. Patient was hospitalized. Patient died on 01/20/2007.

Erlotinib Side Effects Report #6093947-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 24, 2009. Female patient, 72 years of age, weighting 220.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chapped lips, conjunctival irritation, conjunctivitis, dehydration, electrolyte imbalance, erythema, fungal infection

, groin infection, hypophagia. Erlotinib dosage: 150MG QD. During the same period patient was treated with FLUCONAZOLE, PRAVASTATRIN, ATENOLOL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5400121-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on July 27, 2007. Female patient, 71 years of age, weighting 148.4 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abasia, asthenia, back pain

, constipation

, dehydration, diarrhoea, failure to thrive, hypokalaemia. Erlotinib dosage: 150 MG QD PO. Patient died on 07/24/2007.

Erlotinib Side Effects Report #6023554-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Dec 26, 2008. Male patient, 71 years of age, weighting 156.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, dehydration, diarrhoea, liver function test abnormal, pyrexia, renal failure acute, rhabdomyolysis. Erlotinib dosage: 150 MG DAILY 047 PO. During the same period patient was treated with BEVACIZUMAB, ZOFRAN, FENTANYL, MARINOL, RELISTOR, CORTISONE ACETATE, SYTHROID, TRAZODONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6028903-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 05, 2009. Male patient, 71 years of age, weighting 156.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, dehydration, diarrhoea, faecal incontinence, lethargy, liver function test abnormal, pyrexia, renal failure acute, rhabdomyolysis. Erlotinib dosage: 150 MG DAILY 047 PO. During the same period patient was treated with BEVACIZUMAB, ZOFRAN, FENTANYL, MARINOL, RELISTOR, CORTISONE ACETATE, SYTHROID, TRAZODONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6071446-3
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 21, 2009. Male patient, 71 years of age, weighting 157.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, faecal incontinence, loss of consciousness, renal failure acute, rhabdomyolysis. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with BEVACIZUMAB, ZOFRAN, FENTANYL, MARINOL, CORTISONE, SYNTHROID, TRAZODONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4644848-7
Erlotinib side effect was reported by a Physician from on Apr 08, 2005. Female patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, dehydration, dizziness

, syncope. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4700720-5
Erlotinib side effect was reported by a Physician from on June 10, 2005. Female patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abscess

, anorexia, dehydration, dyspnoea, neoplasm progression, respiratory failure, syncope, tumour necrosis. Erlotinib dosage: 150 MG (QD),ORAL. During the same period patient was treated with PREDNISONE, THEOPHYLLINE, HYDROCHLOROTHIAZIDE, ACETYLCYSTEINE, SPIRULINA, FLUTICASONE PROPIONATE, FORMOTEROL. Patient was hospitalized. Patient died on 05/27/2005.

Erlotinib Side Effects Report #4738431-2
Erlotinib side effect was reported by a Physician from PERU on July 22, 2005. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, diarrhoea, hypovolaemic shock, multi-organ failure, rash

. Erlotinib dosage: 150 MG (QD) ORAL. During the same period patient was treated with ISOSORBIDE DINITRATE, CAPTOPRIL, FUROSEMIDE. Patient was hospitalized. Patient died on 04/22/2005.

Erlotinib Side Effects Report #5012296-6
Erlotinib side effect was reported by a Physician from PERU on May 10, 2006. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, diarrhoea, hypovolaemic shock, multi-organ failure, rash

. Erlotinib dosage: unknown. During the same period patient was treated with ISOSORBIDE DINITRATE, CAPTOPRIL, FUROSEMIDE. Patient was hospitalized. Patient died on 04/22/2005.

Erlotinib Side Effects Report #5034583-8
Erlotinib side effect was reported by a Physician from PERU on May 23, 2006. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, diarrhoea, hypovolaemic shock, multi-organ failure, performance status decreased, rash

. Erlotinib dosage: 150 MG 1 X PER DAY / ORAL. During the same period patient was treated with ISOSORBIDE DINITRATE, CAPTOPRIL, FUROSEMIDE. Patient died.

Erlotinib Side Effects Report #5034654-6
Erlotinib side effect was reported by a Physician from PERU on June 05, 2006. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, diarrhoea, hypovolaemic shock, multi-organ failure, performance status decreased, rash

. Erlotinib dosage: unknown. During the same period patient was treated with ISOSORBIDE DINITRATE, CAPTOPRIL, FUROSEMIDE. Patient was hospitalized. Patient died on 04/22/2005.

Erlotinib Side Effects Report #5041328-4
Erlotinib side effect was reported by a Physician from UNITED STATES on June 06, 2006. Female patient, 71 years of age, weighting 129.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: colitis ischaemic, constipation

, dehydration, gastritis, gastrointestinal haemorrhage, haemoglobin decreased, intestinal obstruction, obstruction gastric, urinary tract infection

. Erlotinib dosage: 150 MG, CYCLE 21 DAYS (OD), ORAL. During the same period patient was treated with COLACE, FERROUS SULPHATE, VICODIN. Patient was hospitalized. Patient died on 05/16/2006.

Erlotinib Side Effects Report #5042020-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on June 06, 2006. Female patient, 71 years of age, weighting 129.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain

, colitis ischaemic, constipation

, dehydration, gastritis, haemoglobin decreased, intestinal obstruction, lower gastrointestinal haemorrhage, nausea

. Erlotinib dosage: 150 MG, CYCLE 21 DAYS (OD), ORAL. During the same period patient was treated with COLACE, FERROUS SULPHATE, VICODIN. Patient was hospitalized. Patient died on 05/16/2006.

Erlotinib Side Effects Report #6125590-2
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2009. Male patient, 69 years of age, weighting 136.7 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain

, atrial fibrillation

, blood potassium decreased, dehydration, diarrhoea, leukopenia, performance status decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with ARQ, BISOPROLOL FUMARATE, OMEPRAZOLE. Patient was hospitalized and became disabled. Patient died on 02/28/2009.

Erlotinib Side Effects Report #6055041-8
Erlotinib side effect was reported by a Physician from ITALY on Jan 16, 2009. Female patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atrial fibrillation

, cardiac failure acute, dehydration, diarrhoea, renal failure. Erlotinib dosage: unknown. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5839944-2
Erlotinib side effect was reported by a Physician from UNITED STATES on July 23, 2008. Male patient, 66 years of age, weighting 181.4 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatine increased, blood sodium decreased, blood urea increased, dehydration, gastrooesophageal reflux disease, hyperkalaemia, weight decreased. Erlotinib dosage: (150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5869626-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 19, 2008. Male patient, 66 years of age, weighting 181.4 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain

, blood creatinine increased, blood sodium decreased, blood urea increased, dehydration, dyspnoea, fall

, gastrooesophageal reflux disease, hyperkalaemia. Erlotinib dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient died on 08/12/2008.

Erlotinib Side Effects Report #4832421-7
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 02, 2005. Male patient, 66 years of age, weighting 151.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, dehydration, haemoptysis, malignant neoplasm progression, non-small cell lung cancer. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with AVASTIN. Patient died on 11/01/2005.

Erlotinib Side Effects Report #4832455-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 11, 2005. Female patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: compression fracture, dehydration. Erlotinib dosage: 150 MG, QD. During the same period patient was treated with AVASTIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4941601-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 06, 2006. Female patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: back pain

, compression fracture, dehydration. Erlotinib dosage: 150 MG, QD,. During the same period patient was treated with AVASTIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5930424-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 14, 2008. Male patient, 62 years of age, weighting 147.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood sodium decreased, blood urea increased, dehydration, diarrhoea, fatigue, hyperuricaemia. Erlotinib dosage: (150 MG), ORAL. During the same period patient was treated with VALIUM, FOLIC ACID, HYDROXYCHLOROQUINE SULPHATE, PERCOCET, PROCHLORPERAZINE MALEATE, PREDNISONE, BENAZEPRIL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5956177-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 30, 2008. Male patient, 62 years of age, weighting 147.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood sodium decreased, blood urea increased, dehydration, diarrhoea, fatigue, hyperuricaemia. Erlotinib dosage: (150 MG), ORAL. During the same period patient was treated with VALIUM, FOLIC ACID, HYDROXYCHLOROQUINE SULPHATE, PERCOCET, PROCHLORPERAZINE MALEATE, PREDNISONE, BENAZEPRIL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5259639-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 20, 2007. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, dizziness

, dyspnoea exertional, gait disturbance, movement disorder

, nausea

, oesophageal pain. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5320160-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 18, 2007. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cytomegalovirus oesophagitis, dehydration, diarrhoea, dizziness

, dyspnoea exertional, gait disturbance, movement disorder

, nausea

. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5924656-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 02, 2008. Male patient, 59 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, candidiasis, chronic obstructive pulmonary disease, cough, dehydration, dysphagia, electrolyte imbalance, gait disturbance, mental status changes. Erlotinib dosage: (50 MG), ORAL. During the same period patient was treated with SORAFENIB, PANTOPRAZOLE, ANESTHETIC MOUTH WASH, OXYCODONE WITH APAP, ENOXAPARIN SQ, ZOFRAN IV PM, LORAZEPAM IV PM, POTASSIUM SUPPLEMENT. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5955949-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 27, 2008. Male patient, 59 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, candidiasis, confusional state, cough, dehydration, dysphagia, electrolyte imbalance, mental status changes. Erlotinib dosage: (50 MG, QD), ORAL. During the same period patient was treated with SORAFENIB, PANTOPRAZOLE, ANESTHETIC MOUTH WASH, OXYCODONE WITH APAP, ENOXAPARIN SQ, ZOFRAN IV PM, LORAZEPAM IV PM. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5506949-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 18, 2007. Male patient, 52 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood albumin decreased, blood alkaline phosphatase increased, condition aggravated, dehydration, diarrhoea, lung cancer metastatic, pneumonia

. Erlotinib dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5739357-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 29, 2008. Male patient, 52 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood albumin decreased, blood alkaline phosphatase increased, dehydration, diarrhoea, metastases to lung, pneumonia

, pyrexia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with HYDROCODONE, ACETAMINOPHEN, DIPHENHYDRAMINE, CEPHALEXIN, IBUPROFEN, LOPERAMIDE. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5800628-8
Erlotinib side effect was reported by a Physician from UNITED STATES on July 02, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, dehydration. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5813696-4
Erlotinib side effect was reported by a Physician from UNITED STATES on July 16, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, metabolic acidosis, nausea

. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5875062-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Sept 08, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium difficile toxin test positive, dehydration, diarrhoea, haemoglobin decreased, nausea

, pyrexia. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5916946-9
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 24, 2008. Male patient, 47 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium difficile colitis, dehydration, flatulence, haemoglobin decreased, ileus, pleural effusion, pleural fibrosis, small intestinal obstruction. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with DASATINB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5920061-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 30, 2008. Male patient, 47 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood potassium decreased, blood sodium decreased, clostridium difficile colitis, dehydration, haemoglobin decreased, ileus, nausea

, pyrexia, small intestinal obstruction. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5944242-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 20, 2008. Male patient, 47 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium difficile colitis, dehydration, diarrhoea, haemoglobin decreased, nausea

, pseudomembranous colitis, pyrexia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5716858-X
Erlotinib side effect was reported by a Physician from SAUDI ARABIA on Apr 07, 2008. Male patient, 41 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, post procedural pulmonary embolism, productive cough, sputum discoloured. Erlotinib dosage: (150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5736920-5
Erlotinib side effect was reported by a Pharmacist from SAUDI ARABIA on Apr 25, 2008. Male patient, 41 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, productive cough, pulmonary embolism

, tachycardia, tachypnoea. Erlotinib dosage: (150 MG, QD) , ORAL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5664281-9
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 27, 2008. Female patient, weighting 100.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, disease progression, large intestine perforation, mental status changes, renal failure, urinary tract infection

. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with BEVACIZUMAB, HEPARIN, LEVOTHYROXINE, PREDNISONE, ATENOLOL, FENTANYL, PERCOCET. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5893461-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Sept 22, 2008. Male patient, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium difficile colitis, dehydration. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5985905-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Dec 08, 2008. Male patient, weighting 156.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: body temperature increased, dehydration, diarrhoea. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6050202-6
Erlotinib side effect was reported by a Physician from CANADA on Jan 06, 2009. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anxiety

, dehydration, hypophagia, nausea

, pain

. Erlotinib dosage: unknown. During the same period patient was treated with CISPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6084839-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 04, 2009. Female patient, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, diarrhoea, dyspnoea, hyperkalaemia, hypokalaemia, hypophosphataemia, neutrophilia, vomiting. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6120262-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 04, 2009. Female patient, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, dyspnoea, hyperkalaemia, hypokalaemia, hypophosphataemia, neutrophilia, renal failure. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient died on 02/17/2009.

Erlotinib Side Effects Report #6137759-1
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 11, 2009. Male patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: body temperature decreased, dehydration, diarrhoea, fatigue, hypomagnesaemia, rash

, renal failure acute, renal impairment, thirst. Erlotinib dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4663266-9
Erlotinib side effect was reported by a Physician from on Apr 29, 2005. Male patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypovolaemic shock, multi-organ disorder, rash

. Erlotinib dosage: unknown. During the same period patient was treated with ISOSORBIDE DINITRATE, CAPTOPRIL, FUROSEMIDE. Patient was hospitalized. Patient died on 04/23/2005.

Erlotinib Side Effects Report #6083054-9
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 13, 2009. Male patient, weighting 127.5 lb, was diagnosed with nasopharyngeal cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, hypophagia, lymphopenia, pyrexia, white blood cell count decreased. Erlotinib dosage: 100 MG, QD. During the same period patient was treated with BEVACIZUMAB, CISPLATIN, ONDANSETRON, ACETAMINOFEN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6087966-1
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 19, 2009. Male patient, weighting 127.5 lb, was diagnosed with nasopharyngeal cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, hypophagia, lymphopenia, pyrexia, white blood cell count decreased. Erlotinib dosage: 100 MG, QD. During the same period patient was treated with BEVACIZUMAB, CISPLATIN, ONDANSETRON, ACETAMINOFEN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6092896-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 20, 2009. Male patient, weighting 127.5 lb, was diagnosed with nasopharyngeal cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: constipation

, dehydration, nausea

, pyrexia. Erlotinib dosage: 100 MG, QD. During the same period patient was treated with BEVACIZUMAB, CISPLATIN, ONDANSETRON, ACETAMINOFEN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Erlotinib and dehydration

SideEffects101.com

Erlotinib and dehydration Patient Reports February 11, 2012

side effects of Erlotinib